Light-chain amyloidosis: SCT, novel agents and beyond | Bone Marrow Transplantation
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 | Blood Cancer Journal
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - 2023 - The FEBS Journal - Wiley Online Library
Diagnosis and Management of the Cardiac Amyloidoses | Circulation
Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis – Consult QD
AL Amyloidosis | Amyloidosis Foundation
Light chain amyloidosis pathology. Clonal expansion of plasma cells... | Download Scientific Diagram
Journal of Lancaster General Health - Journal of Lancaster General Hospital
KoreaMed Synapse
AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis | BMC Nephrology | Full Text
Cardiac amyloidosis: An update on diagnosis and treatment | Cleveland Clinic Journal of Medicine
Renal biopsy findings consistent with IgM-kappa type AHL amyloidosis. a... | Download Scientific Diagram
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? - ScienceDirect
Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
Figure 3 from Immunoglobulin light chain amyloid aggregation. | Semantic Scholar
What do I need to know about immunoglobulin light chain (AL) amyloidosis? - ScienceDirect
Frontiers | Understanding AL amyloidosis with a little help from in vivo models
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis | JACC: Basic to Translational Science
Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis | Circulation: Cardiovascular Imaging
AL - Australian Amyloidosis Network
Frontiers | Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder
